摘要
目的:用计算机辅助设计法寻找 HER2/neu受体酪氨酸激酶小分子抑制剂。方法:用 MODERLAR软件模拟出 HER2/neu和 EGFR受体酪氨酸激酶的三维 (three- dimensional,3D)空间结构;根据 HER2/neu酪氨酸激酶 ATP结合区的空间结构,搜索数据库,找出候选化合物;用 Western blot方法检测化合物对 HER2/neu受体酪氨酸激酶磷酸化的影响; MTT法检测细胞增殖抑制作用。结果:比较 HER2/neu和 EGFR(靶蛋白)与胰岛素受体酪氨酸激酶、 FGFR1受体酪氨酸激酶和 Src酪氨酸激酶(模板蛋白)的氨基酸序列发现有 35%~ 41%的相同和 52%~ 55%的相似,用 MODELLER程序模拟出 HER2/neu和 EGFR激酶区域的 3D结构。根据 HER2/neu受体酪氨酸激酶结构模型, 3D数据库的搜索,获得潜在 HER2/neu酪氨酸激酶抑制剂化合物,经筛选、优化发现 ST2325对 HER2/neu磷酸化有明显的抑制作用,其 IC50值为 6.6μ mol/L,且抑制作用是可逆的,对 EGFR受体磷酸化没有抑制作用。 ST2325对 HER2/neu受体表达没有影响。 ST2325对 HER2/neu过表达的肿瘤细胞 MDA- MB- 453 m1的抑制作用更强,而对 EGFR过表达的肿瘤细胞 MDA- MB- 468抑制作用相对较弱,其 IC50值分别为 29.05μ mol/L和 60.40μ mol/L。结论:基于 HER2/neu的结构设计,筛选?
Objective: To discover HER2/neu tyrosine kinase inhibitor through computer- aided drug design approach. Methods: The three- dimensional(3D) structure of HER2/neu and EGFR tyrosine kinase domain was modeled using MODERLAR software. To search database and pick up candidate compounds based 3D structure of HER2/neu tyrosine kinase domain. Inhibition of HER2/neu tyrosine kinase phosphorylation by the compounds was detected using Western blot analysis. Inhibition of cell proliferation was determined by MTT assay. Results: The amino acid identity and similarity between HER2/neu and EGFR kinase domain, insulin receptor kinase domain, FGFR1 kinase domain, Src kinase domain were compared. The identity was 35%- 41% and the similarity was 52%- 55% . The 3D structure of HER2/neu and EGFR was obtained by MODERLAR software. Through searching, screening and optimization, the authors found that ST2325 had significantly inhibitory effect on HER2/neu tyrosine kinase phosphorylation with IC50 of 6.6μ mol/L. The inhibition of HER2/neu phosphorylation was selective and reversible. ST2325 inhibited cell proliferation of HER2/neu- overexpressing MDA- MB- 453m1 preferentially compared with EGFR- overexpressing MDA- MB- 468, The IC50 values were 29.05 and 60.4μ mol/L. Conclusion: ST2325 which was discovered through structure- based approach had notable inhibitory effect on HER2/neu tyrosine kinase.
出处
《癌症》
SCIE
CAS
CSCD
北大核心
2001年第4期341-347,共7页
Chinese Journal of Cancer
基金
国家自然科学基金资助项目!(编号:39900183)